TNF and lung carcinoma: Their in vitro anticancer properties and Tumor necrosis factor alpha (TNF-α-induced) NF-κB activation were evaluated against four human cancer cell lines, such as human ovarian cancer cells (SKOV3), lung cancer cells (A549), liver cancer cells (HepG2), and bladder cancer cells (T24).